162 related articles for article (PubMed ID: 15340761)
1. Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution.
Müller S; Schütt P; Bojko P; Nowrousian MR; Hense J; Seeber S; Moritz T
Ann Hematol; 2005 Feb; 84(2):110-4. PubMed ID: 15340761
[TBL] [Abstract][Full Text] [Related]
2. Gemcitabine-induced hemolytic uremic syndrome in pancreatic cancer: a case report and review of the literature.
Lee HW; Chung MJ; Kang H; Choi H; Choi YJ; Lee KJ; Lee SW; Han SH; Kim JS; Song SY
Gut Liver; 2014 Jan; 8(1):109-12. PubMed ID: 24516709
[TBL] [Abstract][Full Text] [Related]
3. [A 42-year-old patient with the hemolytic-uremic syndrome under gemcitabine therapy for an adenocarcinoma of the liver. The hemolytic-uremic syndrome and gemcitabine].
Eckel F; Lersch C; Erdmann J; Schmidt B; Schulte-Frohlinde E
Z Gastroenterol; 2000 Jul; 38(7):593-6. PubMed ID: 10965557
[TBL] [Abstract][Full Text] [Related]
4. Rituximab to treat gemcitabine-induced hemolytic-uremic syndrome (HUS) in pancreatic adenocarcinoma: a case series and literature review.
Ritchie GE; Fernando M; Goldstein D
Cancer Chemother Pharmacol; 2017 Jan; 79(1):1-7. PubMed ID: 27497971
[TBL] [Abstract][Full Text] [Related]
5. [Hemolytic uremic syndrome as a complication of gemcitabine treatment: report of six cases and review of the literature].
Desramé J; Duvic C; Bredin C; Béchade D; Artru P; Brézault C; Defuentes G; Poirier JM; Dourthe LM; Coutant G; Chaussade S; de Gramont A; Algayres JP
Rev Med Interne; 2005 Mar; 26(3):179-88. PubMed ID: 15777580
[TBL] [Abstract][Full Text] [Related]
6. [Hemolytic uremic syndrome following gemcitabine treatment].
Bourquin V; Guinand A; Haenni C; Giovannini M; Delouche D; Dettwiler S; Moll S
Rev Med Suisse; 2008 Apr; 4(154):1056-61. PubMed ID: 18557535
[TBL] [Abstract][Full Text] [Related]
7. Hemolytic uremic syndrome due to gemcitabine in a young woman with cholangiocarcinoma.
Nieto-Ríos JF; Zuluaga-Quintero M; Higuita LM; Rincón CI; Galvez-Cárdenas KM; Ocampo-Kohn C; Aristizabal-Alzate A; Florez-Vargas AA; Zuluaga-Valencia GA
J Bras Nefrol; 2016 Jun; 38(2):255-9. PubMed ID: 27438981
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine-associated hemolytic-uremic syndrome.
Walter RB; Joerger M; Pestalozzi BC
Am J Kidney Dis; 2002 Oct; 40(4):E16. PubMed ID: 12324937
[TBL] [Abstract][Full Text] [Related]
9. [Hemolytic uremic syndrome induced by gemcitabine. A poorly recognized complication?].
Graas MP; Houbiers G; Demolin G; Stultiens A; Focan C
Rev Med Liege; 2012 Dec; 67(12):644-8. PubMed ID: 23342875
[TBL] [Abstract][Full Text] [Related]
10. Hemolytic-uremic syndrome associated with gemcitabine: a case report and review of literature.
Saif MW; McGee PJ
JOP; 2005 Jul; 6(4):369-74. PubMed ID: 16006690
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine nephrotoxicity and hemolytic uremic syndrome: report of 29 cases from a single institution.
Glezerman I; Kris MG; Miller V; Seshan S; Flombaum CD
Clin Nephrol; 2009 Feb; 71(2):130-9. PubMed ID: 19203505
[TBL] [Abstract][Full Text] [Related]
12. Elevated reticulocyte count--a clue to the diagnosis of haemolytic-uraemic syndrome (HUS) associated with gemcitabine therapy for metastatic duodenal papillary carcinoma: a case report.
Serke S; Riess H; Oettle H; Huhn D
Br J Cancer; 1999 Mar; 79(9-10):1519-21. PubMed ID: 10188900
[TBL] [Abstract][Full Text] [Related]
13. Rapid and complete resolution of chemotherapy-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) with rituximab.
Gourley BL; Mesa H; Gupta P
Cancer Chemother Pharmacol; 2010 Apr; 65(5):1001-4. PubMed ID: 20119714
[TBL] [Abstract][Full Text] [Related]
14. Hemolytic-uremic syndrome caused by gemcitabine.
Nackaerts K; Daenen M; Vansteenkiste J; Vandevelde A; Van Bleyenbergh P; Demedts M
Ann Oncol; 1998 Dec; 9(12):1355. PubMed ID: 9932169
[No Abstract] [Full Text] [Related]
15. Gemcitabine-induced hemolytic uremic syndrome in ovarian carcinoma.
Kalra N; Kad R; Osama S
Int J Clin Oncol; 2007 Oct; 12(5):385-7. PubMed ID: 17929123
[TBL] [Abstract][Full Text] [Related]
16. Chronic anemia resistant to erythropoietin in a patient treated with gemcitabine showing a hemolytic uremic syndrome (HUS).
Assi C; Lepage C; Jouve JL; Sgro C; Bedenne L
Gastroenterol Clin Biol; 2010 Nov; 34(11):640-2. PubMed ID: 21051168
[No Abstract] [Full Text] [Related]
17. Gemcitabine-induced hemolytic-uremic syndrome treated with eculizumab or plasmapheresis: two case reports
.
López Rubio ME; Rodado Martínez R; Illescas ML; Mateo Bosch E; Martinez Díaz M; de la Vara Inesta L; Cabezuelo B; Morales Albuja ME; Lucas Guillén E; Jimeno García L
Clin Nephrol; 2017 Feb; 87 (2017)(2):100-106. PubMed ID: 27879189
[TBL] [Abstract][Full Text] [Related]
18. Rituximab-based therapy for gemcitabine-induced hemolytic uremic syndrome in a patient with metastatic pancreatic adenocarcinoma: a case report.
Bharthuar A; Egloff L; Becker J; George M; Lohr JW; Deeb G; Iyer RV
Cancer Chemother Pharmacol; 2009 Jun; 64(1):177-81. PubMed ID: 19116715
[TBL] [Abstract][Full Text] [Related]
19. Severe hemolytic uremic syndrome in an advanced ovarian cancer patient treated with carboplatin and gemcitabine.
Gross M; Hiesse C; Kriaa F; Goldwasser F
Anticancer Drugs; 1999 Jul; 10(6):533-6. PubMed ID: 10885900
[TBL] [Abstract][Full Text] [Related]
20. A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy.
Fung MC; Storniolo AM; Nguyen B; Arning M; Brookfield W; Vigil J
Cancer; 1999 May; 85(9):2023-32. PubMed ID: 10223245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
